Insider · CIK 0001408502
Mark W Hahn
cfoofficerdirector
Files at SLNO (SOLENO THERAPEUTICS INC), VRNA (Verona Pharma plc). First filing Oct 22, 2024, latest Aug 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 12
$0 bought, $26M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | Verona Pharma plc | $2.7M 208,912 shares | -2% | - | |
| 42Moderate | Verona Pharma plc | $4.6M 400,000 shares | -3% | - | |
| 42Moderate | Verona Pharma plc | $3.7M 400,000 shares | -3% | - | |
| 27Weak | Verona Pharma plc | $5.3M 587,008 shares | -4% | - | |
| 24Weak | Verona Pharma plc | $811k 90,360 shares | -1% | - | |
| 42Moderate | Verona Pharma plc | $4.4M 881,960 shares | -6% | - | |
| 36Weak | Verona Pharma plc | $567k 113,240 shares | -1% | - | |
| 17Weak | Verona Pharma plc | $12k 2,400 shares | -0% | - | |
| 17Weak | Verona Pharma plc | $12k 2,400 shares | -0% | - | |
| 29Weak | Verona Pharma plc | $568k 129,672 shares | -1% | - | |
| 30Weak | Verona Pharma plc | $633k 144,560 shares | -1% | - | |
| 35Weak | Verona Pharma plc | $2.3M 525,768 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 13, 2025 | SLNO SOLENO THERAPEUTICS INC | AGrant or award Common Stock | +10,046 | $0.00 | $0 | 10,046 | Oct 14, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Ordinary Shares | -11,264,968 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +3,285,280 | - | - | 3,285,280 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Ordinary Shares | -3,285,280 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -800,000 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -389,792 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -445,536 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitderivative | +1,649,952 | - | - | 1,649,952 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -1,649,952 | - | - | 0 | Oct 8, 2025 |
| Aug 29, 2025 | VRNA Verona Pharma plc | GGift Ordinary Shares | -1,200,000 | $0.00 | $0 | 11,264,968 | Sep 3, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares10b5-1 | +255,696 | $0.00 | $0 | 12,673,880 | Aug 5, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -208,912 | $13.14 | $2.7M | 12,464,968 | Aug 5, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Stock Unitsderivative10b5-1 | -200,000 | $0.00 | $0 | 800,000 | Aug 5, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Stock Unitsderivative10b5-1 | -55,696 | $0.00 | $0 | 389,792 | Aug 5, 2025 |
| Jul 7, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +229,512 | $0.00 | $0 | 12,508,504 | Jul 9, 2025 |
| Jul 8, 2025 | VRNA Verona Pharma plc | FTax withholding Ordinary Shares | -90,320 | $11.44 | $1.0M | 12,418,184 | Jul 9, 2025 |
| Jul 7, 2025 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitsderivative | +675,048 | $0.00 | $0 | 675,048 | Jul 9, 2025 |
| Jul 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitsderivative | -229,512 | $0.00 | $0 | 445,536 | Jul 9, 2025 |
| Jun 11, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -400,000 | $11.40 | $4.6M | 12,278,992 | Jun 13, 2025 |
| May 27, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -32,432 | $9.53 | $309k | 13,046,560 | May 29, 2025 |
| May 28, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -162,704 | $9.30 | $1.5M | 12,883,856 | May 29, 2025 |
| May 29, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -204,864 | $9.33 | $1.9M | 12,678,992 | May 29, 2025 |
| May 1, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -108,272 | $8.95 | $969k | 13,357,728 | May 5, 2025 |
| May 1, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares10b5-1 | +200,000 | - | - | 13,557,728 | May 5, 2025 |
| May 1, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -78,736 | $8.95 | $705k | 13,478,992 | May 5, 2025 |
| May 2, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -400,000 | $9.09 | $3.6M | 13,078,992 | May 5, 2025 |
| May 1, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitsderivative10b5-1 | -200,000 | $0.00 | $0 | 1,000,000 | May 5, 2025 |
| Apr 29, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares10b5-1 | +229,512 | $0.00 | $0 | 13,556,360 | May 1, 2025 |
| Apr 29, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -90,360 | $8.98 | $811k | 13,466,000 | May 1, 2025 |
| Aug 7, 2024 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitsderivative10b5-1 | +1,200,000 | $0.00 | $0 | 1,200,000 | May 1, 2025 |
| Apr 29, 2025 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitsderivative10b5-1 | +675,000 | $0.00 | $0 | 675,000 | May 1, 2025 |
| Apr 29, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitsderivative10b5-1 | -229,512 | $0.00 | $0 | 445,488 | May 1, 2025 |
| Feb 1, 2025 | VRNA Verona Pharma plc | AGrant or award Ordinary Shares | +200,000 | $0.00 | $0 | 13,493,736 | Feb 4, 2025 |
| Feb 3, 2025 | VRNA Verona Pharma plc | FTax withholding Ordinary Shares | -166,888 | $7.16 | $1.2M | 13,326,848 | Feb 4, 2025 |
| Dec 4, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -58,184 | $5.00 | $291k | 14,117,512 | Dec 6, 2024 |
| Dec 5, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -640,048 | $5.01 | $3.2M | 13,477,464 | Dec 6, 2024 |
| Dec 6, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -183,728 | $5.01 | $920k | 13,293,736 | Dec 6, 2024 |
| Nov 27, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -12,936 | $5.00 | $65k | 14,276,000 | Dec 2, 2024 |
| Nov 29, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -98,704 | $5.01 | $494k | 14,177,296 | Dec 2, 2024 |
| Dec 2, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -1,600 | $5.00 | $8,000 | 14,175,696 | Dec 2, 2024 |
| Nov 25, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -1,600 | $5.00 | $8,000 | 14,289,736 | Nov 26, 2024 |
| Nov 26, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -800 | $5.00 | $4,000 | 14,288,936 | Nov 26, 2024 |
| Nov 11, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -2,400 | $5.00 | $12k | 14,291,336 | Nov 13, 2024 |
| Nov 1, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -48,888 | $4.38 | $214k | 14,374,520 | Nov 5, 2024 |
| Nov 4, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -80,784 | $4.39 | $354k | 14,293,736 | Nov 5, 2024 |
| Oct 30, 2024 | VRNA Verona Pharma plc | AGrant or award Ordinary Shares10b5-1 | +800,000 | $0.00 | $0 | 14,469,360 | Nov 1, 2024 |
| Nov 1, 2024 | VRNA Verona Pharma plc | AGrant or award Ordinary Shares10b5-1 | +200,000 | $0.00 | $0 | 14,669,360 | Nov 1, 2024 |
| Nov 1, 2024 | VRNA Verona Pharma plc | FTax withholding Ordinary Shares10b5-1 | -245,952 | $4.24 | $1.0M | 14,423,408 | Nov 1, 2024 |
| Oct 24, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -141,360 | $4.38 | $619k | 13,672,560 | Oct 25, 2024 |
| Oct 25, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -3,200 | $4.38 | $14k | 13,669,360 | Oct 25, 2024 |
| Oct 18, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -249,728 | $4.38 | $1.1M | 14,089,960 | Oct 22, 2024 |
| Oct 21, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -116,696 | $4.38 | $511k | 13,973,264 | Oct 22, 2024 |
| Oct 22, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -159,344 | $4.38 | $699k | 13,813,920 | Oct 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.